Quick Links: Skip to main page content
Skip to Search
Skip to Topics Menu
Skip to Common Links
U.S. Food & Drug Administration
Follow FDA
En Español
Search FDA
Home
Food
Drugs
Medical Devices
Radiation-Emitting Products
Vaccines, Blood & Biologics
Animal & Veterinary
Cosmetics
Tobacco Products
New Pediatric Labeling Information Database - Detail
FDA Home
Pediatrics
New Pediatric Labeling Information Database
Detail
-
Please note:
JavaScript must be enabled for this application to work properly.
Check your settings
if you are unsure if your JavaScript is enabled.
Pediatric Labeling Date:
12/17/2015
Trade Name:
Emend
Generic Name or Proper Name (*):
aprepitant**
Indications Studied:
Prevention of chemotherapy induced nausea and vomiting in patients ages 6 months of age and older
Label Changes Summary:
*Safety and effectiveness of Emend oral suspension have been established in pediatric patients 6 months and older. *Safety and effectiveness have not been established in patients less than 6 months. *New dosage form.
BPCA(B) and PREA(P):
B, P
Sponsor:
Merck Sharp & Dohme Corp.
NNPS:
FALSE
Therapeutic Category:
Antiemetic
-
-